These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 12379508

  • 1. Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate.
    Itoh Y, Imamura S, Yamamoto K, Ono Y, Nagata M, Kobayashi T, Kato T, Tomita M, Nakai A, Itoh M, Nagasaka A.
    J Endocrinol; 2002 Oct; 175(1):233-9. PubMed ID: 12379508
    [Abstract] [Full Text] [Related]

  • 2. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M.
    Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228
    [Abstract] [Full Text] [Related]

  • 3. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative.
    Itoh Y, Nakai A, Kakizawa H, Makino M, Fujiwara K, Kobayashi T, Kato T, Nagata M, Oda N, Katsumata H, Nagasaka A, Itoh M.
    Horm Res; 2001 Jul; 56(5-6):165-71. PubMed ID: 11910202
    [Abstract] [Full Text] [Related]

  • 4. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Jul; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
    Motawi TK, El-Maraghy SA, Senousy MA.
    J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
    [Abstract] [Full Text] [Related]

  • 6. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
    Ahmed OM, Ali TM, Abdel Gaid MA, Elberry AA.
    PLoS One; 2019 Jul; 14(9):e0214349. PubMed ID: 31527864
    [Abstract] [Full Text] [Related]

  • 7. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B, Oztürk M, Tunçdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E.
    Acta Histochem; 2002 Jul; 104(2):123-30. PubMed ID: 12086332
    [Abstract] [Full Text] [Related]

  • 8. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
    Xu XX, Zhang W, Zhang P, Qi XM, Wu YG, Shen JJ.
    Phytomedicine; 2013 Jul 15; 20(10):820-7. PubMed ID: 23664882
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enalapril attenuates oxidative stress in diabetic rats.
    de Cavanagh EM, Inserra F, Toblli J, Stella I, Fraga CG, Ferder L.
    Hypertension; 2001 Nov 15; 38(5):1130-6. PubMed ID: 11711510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S, Kanter M, Ustundag S, Aktas C, Dogutan H, Yalcin O.
    Ren Fail; 2008 Nov 15; 30(10):1023-33. PubMed ID: 19016156
    [Abstract] [Full Text] [Related]

  • 16. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.
    Ding SS, Qiu C, Hess P, Xi JF, Zheng N, Clozel M.
    J Cardiovasc Pharmacol; 2003 Jul 15; 42(1):48-54. PubMed ID: 12827026
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG, Lin H, Qian H, Zhao M, Qi XM, Wu GZ, Lin ST.
    Inflamm Res; 2006 May 15; 55(5):192-9. PubMed ID: 16830106
    [Abstract] [Full Text] [Related]

  • 19. Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model.
    Chennasamudram SP, Kudugunti S, Boreddy PR, Moridani MY, Vasylyeva TL.
    Nutr Res; 2012 May 15; 32(5):347-56. PubMed ID: 22652374
    [Abstract] [Full Text] [Related]

  • 20. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.